Mode
Text Size
Log in / Sign up
N/A N=14 Basic Science

Agonist-Antagonist Myoneural Interface for Functional Limb Restoration After Transtibial Amputation

Amputation

Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Stability of Joint Position Control in Free Space — 4; 3.1 Distinct synergy activations

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
AMI transtibial amputation (Procedure); Standard transtibial amputation (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts Institute of Technology
Primary completion
Jun 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Stability of Joint Position Control in Free Space
4; 3.1
PRIMARY
Economy of Motion for Free Space Movements
72.42; 69.38; 73.03; 70.29; 73.29; 69.02
PRIMARY
Late Swing Ankle Plantar Flexion During Stair Descent
-15.65; -6.27
PRIMARY
Late Swing Ankle Dorsiflexion During Stair Ascent
19.27; 4.05
SECONDARY
Correlation of Ankle Joint Proprioception
0.77; 0.41; 0.82; 0.5
SECONDARY
Controllability Over Prosthetic Joint Dorsi and Plantar Flexion
0.41; 0.14; 0.24; 0.15

Summary

This study involves the functional testing of a new lower extremity prosthesis by healthy, active participants with fully healed transtibial (below knee) amputations. The study design calls for an experimental group of eleven participants who received two agonist-antagonist myoneural interfaces (AMIs) that were surgically constructed during a modified transtibial amputation procedure, and a control group of eleven matched participants who received standard transtibial amputations. The study protocol involves one or more of the following activities: 1. Collection of electromyography (EMG) data from participants' lower limbs to characterize muscle activation and create maps specific to individual participants, 2. Investigation of participants' capabilities to use a new lower extremity prosthesis that is designed to allow independent actuation of the ankle and subtalar joints, and offers EMG-modulated control over prosthetic joint position and stiffness, and 3. Exploration of AMIs as a means of communicating information between the participant and the new prosthesis using an experimental system involving EMG, functional electrical stimulation, and ultrasound. The hypothesis is that transtibial amputations involving AMIs can offer improved motor control of the new prosthesis while also enabling proprioceptive sensation (perception of the position, movement, and torque of the affected limb and prosthetic joint). The AMIs are expected to improve voluntary prosthetic control, improve prosthetic terrain adaptations, and offer new possibilities for bi-directional communication across the human-device interface.

Eligibility Criteria

Inclusion Criteria

Experimental group participants:

  • Modified transtibial (below knee) amputation incorporating agonist-antagonist myoneural interfaces (AMIs) and performed at the Brigham and Women's Hospital, Boston, MA.
  • Fully healed amputation site
  • Proficiency in using a standard lower extremity prosthesis
  • Activity or K-Level of at least K3 to K4 (capability to ambulate with variable cadence)

Control group participants:

  • Standard transtibial (below knee) amputation
  • Fully healed amputation site
  • Proficiency in using a standard lower extremity prosthesis
  • Activity or K-Level of at least K3 to K4 (capability to ambulate with variable cadence)

Exclusion Criteria

Experimental and Control group participants:

  • Persons beyond the stated age restrictions
  • Persons with one or more of the following underlying health conditions: cardiopulmonary instability manifest as coronary artery disease, chronic obstructive pulmonary disease, and extensive microvascular compromise
  • Persons who are active smokers
  • Persons who are pregnant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03913273). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search